Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Mitochondria-targeting compounds for management of metabolic and hemostatic abnormalities associated with heart dysfunctions in experimental type 2 diabetes

Saved in:
Bibliographic Details
Published in:Endocrine Regulations
Format: Online Article RSS Article
Published: 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868553114829717505
collection WordPress RSS
FRELIP Feed Integration
container_title Endocrine Regulations
description
discipline_display Endocrinology
discipline_facet Endocrinology
format Online Article
RSS Article
genre Journal Article
id rss_article:73741
institution FRELIP
journal_source_facet Endocrine Regulations
last_indexed 2026-06-20T21:31:51.751Z
publishDate 2025
publishDateSort 2025
record_format rss_article
spellingShingle Mitochondria-targeting compounds for management of metabolic and hemostatic abnormalities associated with heart dysfunctions in experimental type 2 diabetes
Endocrinology
General
Endocrinology
sub_discipline_display General
sub_discipline_facet General
subject_display Endocrinology
General
Endocrinology
subject_facet Endocrinology
General
Endocrinology
title Mitochondria-targeting compounds for management of metabolic and hemostatic abnormalities associated with heart dysfunctions in experimental type 2 diabetes
title_alt Compuestos dirigidos a mitocondrias para el manejo de anomalías metabólicas y hemostáticas asociadas con disfunciones cardíacas en diabetes tipo 2 experimental
Composés ciblant les mitochondries pour la gestion des anomalies métaboliques et hémostatiques associées aux dysfonctions cardiaques dans le diabète de type 2 expérimental
Compostos direcionados às mitocôndrias para manejo de anormalidades metabólicas e hemostáticas associadas a disfunções cardíacas em diabetes tipo 2 experimental
title_auth Mitochondria-targeting compounds for management of metabolic and hemostatic abnormalities associated with heart dysfunctions in experimental type 2 diabetes
title_es_txt Compuestos dirigidos a mitocondrias para el manejo de anomalías metabólicas y hemostáticas asociadas con disfunciones cardíacas en diabetes tipo 2 experimental
title_fr_txt Composés ciblant les mitochondries pour la gestion des anomalies métaboliques et hémostatiques associées aux dysfonctions cardiaques dans le diabète de type 2 expérimental
title_full Mitochondria-targeting compounds for management of metabolic and hemostatic abnormalities associated with heart dysfunctions in experimental type 2 diabetes
title_fullStr Mitochondria-targeting compounds for management of metabolic and hemostatic abnormalities associated with heart dysfunctions in experimental type 2 diabetes
title_full_unstemmed Mitochondria-targeting compounds for management of metabolic and hemostatic abnormalities associated with heart dysfunctions in experimental type 2 diabetes
title_pt_txt Compostos direcionados às mitocôndrias para manejo de anormalidades metabólicas e hemostáticas associadas a disfunções cardíacas em diabetes tipo 2 experimental
title_short Mitochondria-targeting compounds for management of metabolic and hemostatic abnormalities associated with heart dysfunctions in experimental type 2 diabetes
title_sort mitochondria-targeting compounds for management of metabolic and hemostatic abnormalities associated with heart dysfunctions in experimental type 2 diabetes
topic Endocrinology
General
Endocrinology
url https://sciendo.com/article/10.2478/enr-2025-0028